A Win for All of Us

Now that our government has narrowly avoided a shutdown, I’d love to share some insights about next year’s federal budget and how we are helping to shape it today. A key goal of Advocacy Day 2021 was to circulate Chairwoman Eshoo and Representative Lofgren’s “e-Dear Colleague” letter, requesting an additional $10 million for the chronic […]

Read More

Why We Support The COVID-19 and Pandemic Response Centers of Excellence Act and the COVID-19 Long Haulers Act

Your advocacy efforts are creating historic opportunities for federal funding of research and ME/CFS education. Two particular pieces of proposed legislation have great potential and I wanted to share my thoughts on each of them Solve M.E. is proud to support The COVID-19 and Pandemic Response Centers of Excellence Act (S. 2307 / H.R.4292). We’re […]

Read More

Will the 21st Century Cures Act Deliver Innovation and Health Breakthroughs for Post-Infection Diseases?

By Emily Taylor, Director of Advocacy and Community Relations Five years ago, the 21st Century Cures Act (Cures Act) was signed into law making national headlines, launching new health initiatives, and spearheading a new chapter in government scientific investment. With robust funding, multiple government agencies rolled out programs designed to accelerate medical product development and […]

Read More

The Path to Diagnostics for ME/CFS: Can Long Covid Pave a Short-Cut?

By Oved Amitay, President and CEO, Solve M.E. It is often said that there are no biomarkers for ME/CFS. In fact, a number of objective measurable biological differences between people with ME/CFS and healthy individuals have been observed over the years. Yet we are missing diagnostic biomarkers that can be readily used to make a […]

Read More

July 2019

ME/CFS RESEARCH: THE SECOND QUARTER OF 2019 IN REVIEW An interactive guide to the promising new discoveries of 2019 Written by Rochelle Joslyn (PhD) Edited by Allison Ramiller (MPH) The second quarter of 2019 brought both an impressive number of ME/CFS publications and highly meaningful content. The momentum in this field is palpable with even a […]

Read More

April 2019

ME/CFS RESEARCH: the first quarter of 2019 in review An interactive guide to the promising new discoveries of 2019  Written by Rochelle Joslyn (PhD) Edited by Allison Ramiller 2019 is off to a strong start for ME/CFS research! From the search for sensitive and specific biomarkers in neuroimaging and CPET testing, to the use of […]

Read More

December 2018

ME/CFS Research: A Year in Review A concise, interactive guide to the promising new discoveries of 2018 Written by Rochelle Joslyn, edited by Allison Ramiller 2018 was a pivotal year for ME/CFS research, yielding over 200 publications addressing various aspects of ME/CFS. Foundational work emerged from prominent biomedical scientists around the globe and powerful new […]

Read More

October 2018

Sailing Ahead: Interim Update from 2017 Ramsay Class Member Prof. Jonas Bergquist Reporting from a tall-ship cruiser, Prof. Bergquist (Uppsala University) tells us a bit more about the Ramsay-supported study he is navigating along with his co-Investigator Prof. Jonas Blomberg. The project is anticipated to wrap up at the end of this year. Prof. Jonas […]

Read More

September 2018

Interim Update from 2017 Ramsay Class member Dr. Eran Segal The lead investigator tells us more about his project exploring the gut microbiota-immune system interaction in ME/CFS Eran Segal, PhD, is a computational biologist specializing in the role of the human microbiome in health and disease. He focuses on the development of personalized medicine approaches that […]

Read More

August 2018

Solve M.E. Funds Study at Columbia University Columbia University Mailman School of Public Health’s Center for Infection & Immunity was funded by Solve M.E. to complete a study aiming to build on recent metabolomics analysis The proteomics analysis is the latest in a series of studies from the Center for Infection and Immunity (CII) on […]

Read More